Want to join the conversation?
St. Louis, Missouri-based pharmacy company $ESRX said that for 4Q15, it delivered adjusted EPS of $1.56, representing growth of 12% over last year. The company adjudicated 341.5MM adjusted claims generating adjusted EBITDA of $1.9Bil, up 4%, resulting in adjusted EBITDA per claim of $5.66. $ESRX generated $2.9Bil of cash flow in 4Q15.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.